文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

AXIN2和SNAIL的表达可预测莫氏显微外科手术后皮肤鳞状细胞癌的复发风险。

AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery.

作者信息

Zhao Guohua, Kim Ki-Yeol, Zheng Zhenlong, Oh Yeongjoo, Yoo Dae San, Lee Myung Eun, Chung Kee Yang, Roh Mi Ryung, Jin Zhehu

机构信息

Department of Dermatology, Yanbian University Hospital, Yanji, Jilin 133000, P.R. China.

Department of Dental Education, BK21 PLUS Project, Yonsei University College of Dentistry, Seoul 03722, Republic of Korea.

出版信息

Oncol Lett. 2020 Mar;19(3):2133-2140. doi: 10.3892/ol.2020.11324. Epub 2020 Jan 21.


DOI:10.3892/ol.2020.11324
PMID:32194711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7039156/
Abstract

Recurrence is a common complication observed during cutaneous squamous cell carcinoma (cSCC) treatment; however, biomarkers for predicting recurrence in cSCC remain unknown. The present study aimed to investigate the predictive value of axis inhibition protein 2 (AXIN2) and SNAIL expression in cSCC recurrence. AXIN2 and SNAIL expression was evaluated using immunohistochemistry in 111 cSCC tissue samples obtained from 18 patients who presented recurrence (recurrence interval, 1-91 months) and 93 patients who did not experience recurrence following Mohs micrographic surgery (MMS) during the follow-up period (156 months). Nomogram construction was performed using patients' clinicopathological characteristics and AXIN2 and SNAIL protein expression. The results demonstrated that high AXIN2 (histoscore >100) and SNAIL (histoscore >100) expression was detected in 35 and 44 cSCC tissues, respectively. Furthermore, the expression levels of AXIN2 and SNAIL were significantly associated in patients with cSCC (P=0.001). AXIN2 and SNAIL expression levels were significantly associated with tumor size (P=0.021 and P=0.044, respectively) and recurrence of cSCC (P=0.017 and P=0.042, respectively). In addition, the results of the Kaplan-Meier curve analysis revealed that recurrence-free survival was significantly associated with tumor size (P=0.025), differentiation status (P<0.001), AXIN2 expression (P=0.001) and SNAIL expression (P=0.001). Furthermore, the results of the multivariate analysis demonstrated that age (P=0.043), AXIN2 expression (P=0.001) and SNAIL expression (P=0.045) were independent risk factors for cSCC recurrence in the present cohort. A nomogram for predicting the 1-, 2-, 3-, and 5-year recurrence-free survival was developed for patients with cSCC by including independent risk factors with a concordance index of 0.75. The results suggested that high AXIN2 and SNAIL expression may be considered as potential risk factors for cSCC recurrence. This nomogram may therefore be useful to assess the probability of recurrence in patients with cSCC following MMS.

摘要

复发是皮肤鳞状细胞癌(cSCC)治疗过程中常见的并发症;然而,预测cSCC复发的生物标志物仍不明确。本研究旨在探讨轴抑制蛋白2(AXIN2)和SNAIL表达在cSCC复发中的预测价值。采用免疫组织化学方法对111例cSCC组织样本中AXIN2和SNAIL的表达进行评估,这些样本来自18例出现复发的患者(复发间隔为1 - 91个月)以及93例在随访期(156个月)接受莫氏显微外科手术(MMS)后未复发的患者。利用患者的临床病理特征以及AXIN2和SNAIL蛋白表达构建列线图。结果显示,分别在35例和44例cSCC组织中检测到高AXIN2(组织评分>100)和SNAIL(组织评分>100)表达。此外,cSCC患者中AXIN2和SNAIL的表达水平显著相关(P = 0.001)。AXIN2和SNAIL表达水平分别与肿瘤大小(P = 0.021和P = 0.044)以及cSCC复发显著相关(P = 0.017和P = 0.042)。此外,Kaplan - Meier曲线分析结果显示,无复发生存期与肿瘤大小(P = 0.025)、分化状态(P < 0.001)、AXIN2表达(P = 0.001)和SNAIL表达(P = 0.001)显著相关。此外,多因素分析结果表明,年龄(P = 0.043)、AXIN2表达(P = 0.001)和SNAIL表达(P = 0.045)是本队列中cSCC复发的独立危险因素。通过纳入独立危险因素,为cSCC患者绘制了预测1年、2年、3年和5年无复发生存率的列线图,一致性指数为0.75。结果表明,AXIN2和SNAIL高表达可能被视为cSCC复发的潜在危险因素。因此,该列线图可能有助于评估MMS后cSCC患者的复发概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/2d5171a829c7/ol-19-03-2133-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/ac2c8752cfcf/ol-19-03-2133-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/2b35f90c880c/ol-19-03-2133-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/e69528c1817b/ol-19-03-2133-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/2d5171a829c7/ol-19-03-2133-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/ac2c8752cfcf/ol-19-03-2133-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/2b35f90c880c/ol-19-03-2133-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/e69528c1817b/ol-19-03-2133-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6255/7039156/2d5171a829c7/ol-19-03-2133-g03.jpg

相似文献

[1]
AXIN2 and SNAIL expression predict the risk of recurrence in cutaneous squamous cell carcinoma after Mohs micrographic surgery.

Oncol Lett. 2020-3

[2]
A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma.

BMC Cancer. 2022-11-3

[3]
Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.

Oral Oncol. 2017-8-12

[4]
Mohs Micrographic Surgery for Cutaneous Squamous Cell Carcinoma.

Cancers (Basel). 2024-6-28

[5]
Clinical Versus Histologic Margins for Cutaneous Squamous Cell Carcinoma: Comparing Outcomes for High-Risk Tumors Treated With Mohs Micrographic Surgery.

Dermatol Surg. 2024-11-1

[6]
Risk Factors of Microscopically Tumor-Free Surgical Margins for Recurrence and Survival of Oral Squamous Cell Carcinoma Patients.

Front Oncol. 2022-7-7

[7]
Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.

J Am Acad Dermatol. 2019-7-3

[8]
Impact of Mohs Micrographic Surgery on Tumor Staging of Cutaneous Squamous Cell Carcinoma: A Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Guidelines.

Dermatol Surg. 2018-8

[9]
Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.

Br J Dermatol. 2018-10-28

[10]
A deep learning algorithm to detect cutaneous squamous cell carcinoma on frozen sections in Mohs micrographic surgery: a retrospective assessment.

medRxiv. 2023-5-16

引用本文的文献

[1]
Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation.

Mol Cancer. 2025-4-2

[2]
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis.

NPJ Digit Med. 2025-2-15

[3]
Self-supervised artificial intelligence predicts recurrence, metastasis and disease specific death from primary cutaneous squamous cell carcinoma at diagnosis.

Res Sq. 2023-12-13

[4]
Proteasome Subunit Alpha Type-7 Expression Suppresses Cutaneous Squamous Cell Carcinoma Progression by Inhibiting Cancer-associated Cytokines.

In Vivo. 2023

[5]
A nomogram combining clinical factors and biomarkers for predicting the recurrence of high-risk cutaneous squamous cell carcinoma.

BMC Cancer. 2022-11-3

[6]
Risk Factors of Microscopically Tumor-Free Surgical Margins for Recurrence and Survival of Oral Squamous Cell Carcinoma Patients.

Front Oncol. 2022-7-7

[7]
Role of immunohistochemistry in the diagnosis and staging of cutaneous squamous-cell carcinomas (Review).

Exp Ther Med. 2022-6

[8]
SNAIL1: Linking Tumor Metastasis to Immune Evasion.

Front Immunol. 2021

[9]
The Expression of Selected Wnt Pathway Members (FZD6, AXIN2 and β-Catenin) in Canine Oral Squamous Cell Carcinoma and Acanthomatous Ameloblastoma.

Animals (Basel). 2021-5-29

[10]
MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis.

Int J Gen Med. 2021-1-8

本文引用的文献

[1]
TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.

J Am Acad Dermatol. 2018-8-28

[2]
Nomograms and risk scores for predicting the risk of oral cancer in different sexes: a large-scale case-control study.

J Cancer. 2018-6-22

[3]
PD-L1 Expression is Increased in Metastasizing Squamous Cell Carcinomas and Their Metastases.

Am J Dermatopathol. 2018-9

[4]
Mohs micrographic surgery for cutaneous malignancies: A focus review of its indications in pediatric age groups.

Pediatr Dermatol. 2018-7

[5]
Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.

JAMA Dermatol. 2018-4-1

[6]
Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.

J Am Acad Dermatol. 2018-2

[7]
Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea.

Cancer Res Treat. 2017-7-14

[8]
[Single center analysis of the dermatosurgical patient cohort of a tumor center in Germany].

Hautarzt. 2017-5

[9]
Wnt1 and SFRP1 as potential prognostic factors and therapeutic targets in cutaneous squamous cell carcinoma.

Genet Mol Res. 2016-6-20

[10]
Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.

Am J Clin Dermatol. 2016-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索